The telehealth company Hims & Hers put out a Super Bowl ad that skimped on clarifying that its compounded semaglutide ...

Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...

Controversy surrounded Hims & Hers’ commercial, called ‘Sick of the System’, in the lead up to America’s biggest sporting ...

Detailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.

The Super Bowl spot is a strikingly dark, politicized way of getting at the company’s latest initiative: selling weight-loss drugs ... and Facebook. Hims sells all manner of pills, supplements ...

Hims has more recently tapped into the surging demand for weight-loss services via GLP-1 and oral ... the company is still a solid buy given its growth rate in a highly promising industry.

The Super Bowl spot is a strikingly dark, politicized way of getting at the company’s latest initiative: selling weight-loss drugs to both women ... across Instagram and Facebook. Hims sells all ...

Trump could either weaken the negotiations in a way that benefits the pharmaceutical industry, or try to achieve even deeper ...

The 50 mg oral semaglutide pill achieved a 15.1% weight loss in the phase 3 OASIS study ... Bain Capital has agreed to buy Mitsubishi Tanabe for around $3.4 bn, setting up one of the largest ...